Are Respiratory Deaths Underreported? - Scorecard - MDSpire

Are Respiratory Deaths Underreported?

Postmortem testing reveals gaps in respiratory virus diagnosis

  • April 21, 2026

  • 3 min

Share

Clinical Scorecard: Are Respiratory Deaths Underreported?

At a Glance

CategoryDetail
ConditionRespiratory viral infections in deceased individuals during winter months
Key MechanismsRespiratory viruses detected postmortem using PCR testing; underdiagnosis before death
Target PopulationIndividuals dying during winter seasons, including older and vulnerable patients
Care SettingCommunity, long-term care, and hospital settings

Key Highlights

  • 36% of postmortem samples tested positive for respiratory viruses, mainly rhinovirus and influenza.
  • Only 1.4% of deaths had influenza listed as cause despite 11% testing positive postmortem.
  • Low pre-death respiratory virus testing (11%) suggests many infections go unrecognized.

Guideline-Based Recommendations

Diagnosis

  • Utilize molecular diagnostic tools such as multiplex PCR to detect multiple respiratory viruses.
  • Increase respiratory virus testing in vulnerable patients, especially during peak winter periods.

Management

  • Consider respiratory viral infections in clinical assessments of vulnerable and older patients.
  • Broaden use of molecular diagnostics to improve detection and management.

Monitoring & Follow-up

  • Enhance surveillance systems to better capture respiratory virus-related mortality.
  • Implement more consistent testing protocols in community and long-term care settings.

Risks

  • Underdiagnosis of respiratory viral infections may lead to underestimation of their role in mortality.
  • Co-infections with multiple viruses can occur, particularly in older or vulnerable populations.

Patient & Prescribing Data

Deceased individuals during winter months, including older and vulnerable groups

Limited pre-death testing indicates potential missed opportunities for antiviral or supportive therapies.

Clinical Best Practices

  • Incorporate multiplex PCR testing for respiratory viruses in patients with suspected infections.
  • Maintain high clinical suspicion for respiratory viral infections in vulnerable populations during winter.
  • Improve diagnostic and surveillance strategies to better understand respiratory virus mortality impact.

Related Resources & Content

Original Source(s)

Are Respiratory Deaths Underreported?

  • April 21, 2026

Related Content

Can Consumer Wearables Support PASC Monitoring?

Heart rate monitoring and atrial fibrillation detection had the strongest supporting evidence, but investigators found limited evidence for broader outpatient self-monitoring applications.

VA DOD Updates Asthma Framework

The 2025 US Department of Veterans Affairs and US Department of Defense asthma guideline introduces 21 evidence-based recommendations for primary care, redefining stepwise treatment, comorbidity management, and reliever strategy.

Amoxicillin-Clavulanate vs Amoxicillin for Sinusitis

Amoxicillin-clavulanate was not linked to lower treatment failure but was associated with a slightly higher risk of secondary infections compared with amoxicillin in adults with uncomplicated acute sinusitis.